DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,538,000 | -43.0% | 76,299 | +5.4% | 0.00% | -100.0% |
| Q2 2021 | $2,700,000 | +35.0% | 72,371 | -7.4% | 0.00% | – |
| Q1 2021 | $2,000,000 | -40.2% | 78,183 | -48.5% | 0.00% | -100.0% |
| Q4 2020 | $3,345,000 | +18.1% | 151,792 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $2,833,000 | -27.5% | 157,473 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $3,907,000 | +266.2% | 153,812 | +165.1% | 0.00% | – |
| Q1 2020 | $1,067,000 | -63.0% | 58,020 | -55.7% | 0.00% | -100.0% |
| Q4 2019 | $2,887,000 | +215.5% | 131,081 | +105.7% | 0.00% | – |
| Q3 2019 | $915,000 | +102.0% | 63,715 | +121.6% | 0.00% | – |
| Q2 2019 | $453,000 | -6.2% | 28,754 | -12.8% | 0.00% | – |
| Q1 2019 | $483,000 | +37.2% | 32,970 | +0.0% | 0.00% | – |
| Q4 2018 | $352,000 | -25.6% | 32,960 | +6.5% | 0.00% | – |
| Q3 2018 | $473,000 | +32.1% | 30,935 | +5.8% | 0.00% | – |
| Q2 2018 | $358,000 | – | 29,242 | +20787.1% | 0.00% | – |
| Q2 2017 | $0 | – | 140 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 140 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 140 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 140 | -98.5% | 0.00% | – |
| Q1 2016 | $51,000 | -92.9% | 9,554 | -84.2% | 0.00% | – |
| Q4 2015 | $717,000 | +71600.0% | 60,382 | +84945.1% | 0.00% | – |
| Q3 2015 | $1,000 | -90.9% | 71 | -90.6% | 0.00% | – |
| Q2 2015 | $11,000 | +37.5% | 756 | +134.8% | 0.00% | – |
| Q1 2015 | $8,000 | +166.7% | 322 | +95.2% | 0.00% | – |
| Q4 2014 | $3,000 | +50.0% | 165 | +1.2% | 0.00% | – |
| Q3 2014 | $2,000 | -66.7% | 163 | -35.6% | 0.00% | – |
| Q2 2014 | $6,000 | – | 253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |